Asunto(s)
Control de Medicamentos y Narcóticos/tendencias , Alucinógenos/uso terapéutico , Legislación de Medicamentos/tendencias , Investigación Farmacéutica , Reposicionamiento de Medicamentos/métodos , Alucinógenos/metabolismo , Humanos , Trastornos Mentales/tratamiento farmacológico , Trastornos Mentales/metabolismo , Neurobiología , Dolor/tratamiento farmacológico , Investigación Farmacéutica/métodos , Investigación Farmacéutica/tendencias , Psiquiatría/tendenciasRESUMEN
Men and women (50-67 years) completed drinking diaries and, on the basis of this, were divided into low (<2 units/day, 1 UK unit=8 g alcohol) and moderate (2-5 units/day) alcohol groups. They completed analogue rating scales of mood and bodily symptoms before and after two extended computerised cognitive tests. After the tests, the women showed significantly greater increases in self-ratings on the factors of anxiety and discontentment and felt significantly less alert than did the men. They also showed significantly greater increases in bodily symptoms of somatic anxiety and ratings of aggressive mood than did the men. There were no significant effects of alcohol or Sex x Alcohol interactions on the self-ratings, but the men showed significant positive correlations of alcohol and negative mood. On both the cognitive tests, there were significant Sex x Alcohol interactions because the moderate-drinking men performed worse than the low-drinking men, whereas the moderate-drinking women performed better than the low-drinking women. Thus, the middle-aged women responded much more than did the men with negative mood changes to the psychological stress of cognitive testing, although their cognitive performance was not worse.
Asunto(s)
Afecto , Consumo de Bebidas Alcohólicas/psicología , Cognición , Anciano , Agresión , Ansiedad/etiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas Psicológicas , Caracteres SexualesRESUMEN
RATIONALE: Unconditioned anxiogenic effects of nicotine have been observed in the social interaction (SI) test 5 min after injection of a low dose and both 5 min and 30 min after injection of a high dose. Conditioned anxiety has also been observed 24 h after testing in the SI with a high dose of nicotine. OBJECTIVES: In order to determine whether these three anxiogenic effects shared a common mechanism, we investigated the role of corticotropin releasing factor (CRF). We therefore examined whether the CRF antagonist alpha-helical CRF(9-41) could block these three anxiogenic effects of nicotine. METHODS: To test the unconditioned anxiogenic effects, pairs of male rats were tested in SI 5 min after s.c. vehicle or nicotine (0.1 mg/kg) or 30 min after s.c. vehicle or nicotine (0.45 mg/kg), and 30 min after i.c.v. artificial cerebrospinal fluid (aCSF) or alpha-helical CRF(9-41). To test conditioned anxiety, rats were exposed to the SI test on day 1, 5 min after vehicle or nicotine (0.1 mg/kg). On day 2, they were re-tested in SI 30 min after i.c.v. aCSF or alpha-helical CRF(9-41) (5 microg). RESULTS: alpha-Helical CRF(9-41) did not block the unconditioned anxiogenic effect of either dose of nicotine. Nicotine (0.1 mg/kg, 5 min) elicited a conditioned anxiogenic response that was significantly reversed by alpha-helical CRF(9-41). The CRF antagonist alone had no effect. CONCLUSIONS: CRF is an important mediator of the conditioned anxiety to nicotine, but may not play a role in mediating the acute anxiogenic effects.
Asunto(s)
Ansiedad , Condicionamiento Psicológico/efectos de los fármacos , Hormona Liberadora de Corticotropina/antagonistas & inhibidores , Hormona Liberadora de Corticotropina/farmacología , Nicotina/farmacología , Fragmentos de Péptidos/farmacología , Animales , Relación Dosis-Respuesta a Droga , Vías de Administración de Medicamentos , Interacciones Farmacológicas , Relaciones Interpersonales , Masculino , Actividad Motora/efectos de los fármacos , Nicotina/antagonistas & inhibidores , Agonistas Nicotínicos/farmacología , Ratas , Factores de TiempoRESUMEN
RATIONALE: Most commercial rodent diets are formulated with soya protein and therefore contain soya isoflavones. Isoflavones form one of the main classes of phytoestrogens and have been found to exert both oestrogenic and anti-oestrogenic effects on the central nervous system. The effects have not been limited to reproductive behaviour, but include effects on learning and anxiety and actions on the hypothalamo-pituitary axis. It is therefore possible that the soya content of diet could have significant effects on brain and behaviour and be an important source of between-laboratory variability. OBJECTIVES: To determine whether behaviour in two animal tests of anxiety, and stress hormone production, would differ between rats that were fed a diet which was free of soya isoflavones and other phytoestrogens (iso-free) and those that were fed a diet which contained 150 microg/g of the isoflavones genistein and daidzein (iso-150). This controlled diet has an isoflavone concentration similar to that in the maintenance diet routinely used in our institution. METHODS: Male rats were randomly allocated to the iso-free and iso-150 diets and their body weights and food and water consumption were recorded for 14 days. They were then maintained on the same diets, but housed singly for 4 days, before testing in the social interaction and elevated plus-maze tests of anxiety. Corticosterone concentrations in both dietary groups were determined under basal conditions and after the stress of the two tests of anxiety. Vasopressin and oxytocin concentrations were determined after brief handling stress. RESULTS: The groups did not differ in food or water intake, body weight or oxytocin concentrations. Compared with the rats fed the iso-free diet, the rats fed the iso-150 diet spent significantly less time in active social interaction and made a significantly lower percentage of entries onto the open arms of the plus-maze, indicating anxiogenic effects in both animal tests. The groups did not differ in their basal corticosterone concentrations, but the iso-150 group had significantly elevated stress-induced corticosterone concentrations. Stress-induced plasma vasopressin concentrations were also significantly elevated in the iso-150 diet group compared with the iso-free rats. CONCLUSIONS: Major changes in behavioural measures of anxiety and in stress hormones can result from the soya isoflavone content of rat diet. These changes are as striking as those seen following drug administration and could form an important source of variation between laboratories.
Asunto(s)
Ansiedad/metabolismo , Corticosterona/metabolismo , Estrógenos no Esteroides/farmacología , Isoflavonas/farmacología , Oxitocina/metabolismo , Vasopresinas/metabolismo , Animales , Ansiedad/psicología , Corticosterona/sangre , Dieta , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/metabolismo , Isoflavonas/sangre , Isoflavonas/metabolismo , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Oxitocina/sangre , Fitoestrógenos , Preparaciones de Plantas , Distribución Aleatoria , Ratas , Conducta Social , Vasopresinas/sangreRESUMEN
The social interaction test of anxiety was developed 25 years ago to provide an ethologically based test that was sensitive to both anxiolytic and anxiogenic effects. It is sensitive to a number of environmental and physiological factors that can affect anxiety. It has detected anxiogenic effects of peptides such as corticotropin-releasing factor (CRF) and adrenocorticotropic hormone (ACTH), and anxiolytic effects of neuropeptide Y and substance P receptor antagonists. It has successfully identified neuropharmacological sites of action of anxiogenic compounds and drug withdrawal. Effects of compounds acting on the gamma-aminobutyric acid (GABA) and 5-hydroxytryptamine (5-HT) systems have been extensively investigated after both systemic administration and microinjection into specific brain regions. The use of this test has, thus, played a crucial role in unravelling the neural basis of anxiety. It is hoped that in the next 25 years, the test will play a crucial role in determining the genetic basis of anxiety disorders.
Asunto(s)
Ansiedad/psicología , Modelos Animales de Enfermedad , Neurotransmisores/metabolismo , Conducta Social , Animales , Ansiolíticos/farmacología , Ansiedad/inducido químicamente , Ansiedad/metabolismo , Conducta Animal/efectos de los fármacos , Encéfalo/fisiopatología , Ambiente , Neuropéptidos/metabolismo , Neuropéptidos/farmacología , Neurotransmisores/farmacología , Síndrome de Abstinencia a Sustancias/etiología , Síndrome de Abstinencia a Sustancias/psicologíaRESUMEN
This review focuses on nicotinic--serotonergic interactions in the central nervous system (CNS). Nicotine increases 5-hydroxytryptamine (5-HT) release in the cortex, striatum, hippocampus, dorsal raphé nucleus (DRN), hypothalamus, and spinal cord. As yet, there is little firm evidence for nicotinic receptors on serotonergic terminals and thus nicotine's effects on 5-HT may not necessarily be directly mediated, but there is strong evidence that the 5-HT tone plays a permissive role in nicotine's effects. The effects in the cortex, hippocampus, and DRN involve stimulation of 5-HT(1A) receptors, and in the striatum, 5-HT(3) receptors. The 5-HT(1A) receptors in the DRN play a role in mediating the anxiolytic effects of nicotine and the 5-HT(1A) receptors in the dorsal hippocampus and lateral septum mediate its anxiogenic effects. The increased startle and anxiety during nicotine withdrawal is mediated by 5-HT(1A) and 5-HT(3) receptors. The locomotor stimulant effect of acute nicotine is mediated by 5-HT(1A) receptors and 5-HT(2) receptors may play a role in the expression of a sensitised response after chronic nicotine treatment. Unfortunately, the role of 5-HT(1A) receptors in mediating nicotine seeking has not yet been investigated and would seem an important area for future research. There is also evidence for nicotinic--serotonergic interactions in the acquisition of the water maze, passive avoidance, and impulsivity in the five-choice serial reaction task.